DK171890B1 - Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden - Google Patents

Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden Download PDF

Info

Publication number
DK171890B1
DK171890B1 DK183882A DK183882A DK171890B1 DK 171890 B1 DK171890 B1 DK 171890B1 DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A DK 171890 B1 DK171890 B1 DK 171890B1
Authority
DK
Denmark
Prior art keywords
group
acids
salts
ethyl ester
integer
Prior art date
Application number
DK183882A
Other languages
Danish (da)
English (en)
Other versions
DK183882A (da
Inventor
Klaus Eistetter
Gerhard Ludwig
Erich Rapp
Horst Wolf
Original Assignee
Wolf Horst P O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolf Horst P O filed Critical Wolf Horst P O
Publication of DK183882A publication Critical patent/DK183882A/da
Application granted granted Critical
Publication of DK171890B1 publication Critical patent/DK171890B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK183882A 1980-08-25 1982-04-23 Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden DK171890B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH639780 1980-08-25
CH152681 1981-03-06
CH152681 1981-03-06
EP8100136 1981-08-24
PCT/EP1981/000136 WO1982000643A1 (en) 1980-08-25 1981-08-24 Substituted oxiranecarbonic acids,preparation and pharmaceutical utilisation thereof

Publications (2)

Publication Number Publication Date
DK183882A DK183882A (da) 1982-04-23
DK171890B1 true DK171890B1 (da) 1997-08-04

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183882A DK171890B1 (da) 1980-08-25 1982-04-23 Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden

Country Status (16)

Country Link
US (1) US4337267A (ja)
EP (1) EP0046590B1 (ja)
JP (1) JPS6059914B2 (ja)
AU (1) AU549447B2 (ja)
CA (1) CA1167050A (ja)
DE (1) DE3170608D1 (ja)
DK (1) DK171890B1 (ja)
ES (1) ES8300730A1 (ja)
GR (1) GR75741B (ja)
IE (1) IE51534B1 (ja)
IL (1) IL63627A (ja)
NZ (1) NZ198136A (ja)
PH (1) PH21847A (ja)
PT (1) PT73563B (ja)
WO (1) WO1982000643A1 (ja)
YU (1) YU206681A (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680507D1 (de) * 1985-08-02 1991-08-29 Byk Gulden Lomberg Chem Fab Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.
EP0283168A3 (en) * 1987-03-16 1989-06-14 American Home Products Corporation Fluorooxirane carboxylates
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
WO1998000422A1 (en) * 1996-07-02 1998-01-08 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
ES2400683T3 (es) * 2001-09-26 2013-04-11 Emisphere Technologies, Inc. Método de preparación de ácidos fenoi-alcanoicos y sales de los mismos mediante un producto intermedio de dicarboxilato
US7705016B2 (en) * 2003-02-13 2010-04-27 Albert Einstein College Of Medicine Of Yeshiva University Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
WO2006088875A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels
DK2310003T3 (da) 2008-06-27 2020-05-18 Cptone Biotech Aps Inhibitorer af Carnitin-Palmitoyl-Transferase-1 til behandling og forebyggelse af lidelser forårsaget af delipidering af neuralt væv
EP3307262B1 (en) 2015-06-15 2021-05-19 NMD Pharma A/S Compounds for use in treating neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
CA1103260A (en) * 1975-09-22 1981-06-16 Richard J. Mohrbacher .alpha.-ALKYL-SUBSTITUTED GLYCIDATES AND THIOGLYCIDATES
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
DE3063144D1 (en) * 1979-09-07 1983-06-16 Byk Gulden Lomberg Chem Fab Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them

Also Published As

Publication number Publication date
ES504922A0 (es) 1982-11-16
JPS57501233A (ja) 1982-07-15
DE3170608D1 (en) 1985-06-27
IL63627A (en) 1984-11-30
ES8300730A1 (es) 1982-11-16
EP0046590A3 (en) 1982-04-07
YU206681A (en) 1983-10-31
AU7447581A (en) 1982-03-04
EP0046590A2 (de) 1982-03-03
NZ198136A (en) 1983-12-16
GR75741B (ja) 1984-08-02
PH21847A (en) 1988-03-17
PT73563B (en) 1983-07-14
PT73563A (en) 1981-09-01
WO1982000643A1 (en) 1982-03-04
DK183882A (da) 1982-04-23
US4337267A (en) 1982-06-29
CA1167050A (en) 1984-05-08
IE51534B1 (en) 1987-01-07
IL63627A0 (en) 1981-11-30
JPS6059914B2 (ja) 1985-12-27
AU549447B2 (en) 1986-01-30
IE811931L (en) 1982-02-25
EP0046590B1 (de) 1985-05-22

Similar Documents

Publication Publication Date Title
DK171890B1 (da) Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden
EP0144804B1 (en) New 2,5-diaryl tetrahydrofurans and analogs thereof as paf-antagonists
CA1149404A (en) Substituted oxiranecarboxylic acids, processes for their preparation, their use and medicaments containing them
US4430339A (en) Substituted oxiranecarboxylic acids, their preparation and their use as medicaments
DK159114B (da) Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser
US4334089A (en) Substituted oxocarboxylic acids, processes for their preparation, their use and medicaments containing them
EP0154887B1 (en) New 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists
SU1001856A3 (ru) Способ получени фенилпиперазинпроизводных 1,3,4-оксадиазолилфенола или их кислотно-аддитивных солей
IE55377B1 (en) 1,5-diphenylpyrazolin-3-one compounds,method for preparing them,and pharmaceutical compositions containing these compounds
GB2171997A (en) 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives
WO1983000334A1 (en) Phenylalkyloxirane carboxylic acids, preparation and therapeutical use
CA1163644A (en) Process for the preparation of epoxycycloalkylalkanecarboxylic acids
US4146728A (en) Esters of 2-[4-(4-chlorobenzoyl)-phenoxy-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes
JPS632988A (ja) １，３−ジチオ−ル−２−イリデン　スルホニル酢酸誘導体
EP0374885B1 (en) Antiretroviral aryloxy substituted furan ketones
KR950003499B1 (ko) 1,3,5-트리티안 유도체
NZ199837A (en) Epoxycycloalkylalkanecarboxylic acids and pharmaceutical compositions
EP0103503A2 (fr) Amides N-substitués, leurs sels, procédé pour leur préparation et compositions pharmaceutiques en contenant
JPH03197463A (ja) 新規ベンズアゼピン
JPH05239014A (ja) 置換フェニルスルホニルアミノアルカン酸誘導体
BE861550A (fr) Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques
KR20030092300A (ko) 푸마질롤 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
ARF Application refused